Global burden of liver disease: 2023 update
Liver disease accounts for two million deaths annually and is responsible for 4% of all
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related …
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
DQ Huang, P Mathurin, H Cortez-Pinto… - Nature reviews …, 2023 - nature.com
Heavy alcohol consumption is a major cause of morbidity and mortality. Globally, alcohol per-
capita consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to …
capita consumption rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to …
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Preventing SARS-CoV-2 infection by modulating viral host receptors, such as angiotensin-
converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for …
converting enzyme 2 (ACE2), could represent a new chemoprophylactic approach for …
COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans
The majority of people infected with SARS-CoV-2 fully recovered within a few weeks.
However, a considerable number of patients of different ages still suffer from long-lasting …
However, a considerable number of patients of different ages still suffer from long-lasting …
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
M Cornberg, M Buti, CS Eberhardt, PA Grossi… - Journal of …, 2021 - Elsevier
According to a recent World Health Organization estimate, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …
syndrome coronavirus 2 (SARS-CoV-2) pandemic, which originated in China in 2019, has …
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
PJ Thuluvath, P Robarts, M Chauhan - Journal of hepatology, 2021 - Elsevier
Background & Aims Liver transplant (LT) recipients or other immunocompromised patients
were not included in the registration trials studying the efficacy of vaccines against SARS …
were not included in the registration trials studying the efficacy of vaccines against SARS …
SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
DF Ruether, GM Schaub, PM Duengelhoef… - Clinical …, 2022 - Elsevier
Background & Aims Detailed information on the immune response after second vaccination
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
of cirrhotic patients and liver transplant (LT) recipients against severe acute respiratory …
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
No specific antiviral drugs have been approved for the treatment of COVID-19. This study
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
Risk factors of severe COVID-19: a review of host, viral and environmental factors
The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …
asymptomatic infections to severe disease and death. Understanding the risk factors of …